Search Results
Keywords: epidiolex
FDA advisory panel gives thumbs-up to CBD epilepsy treatment
A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market.
Here’s how the FDA’s review of epilepsy drug could affect CBD companies
It’s shaping up to be a watershed summer for the cannabis industry with the U.S. Food and Drug Administration poised to approve the first drug made from the plant.
Impending ruling on epilepsy drug has CBD industry on alert
The most disruptive product to hit the newly legal hemp industry might be one that will never be sold directly to consumers.
GW Pharmaceuticals, a London-based biotech company, is awaiting a final decision from the U.S. Food and Drug Administration to produce the first cannabis-derived treatment to win approval as legal medicine.
A look ahead: Challenges, opportunities for marijuana professionals in new year
The marijuana industry is strapping in for a roller-coaster 2018, when challenges and opportunities are unfolding faster than ever, and in more places than ever.
Here’s a look at 11 challenges and opportunities that will demand the attention of marijuana entrepreneurs in 2018:
British Sugar to grow cannabis for GW Pharma
GW Pharmaceuticals, the British developer of a CBD-based anti-seizure medicine that could be on American shelves in 2018, has contracted Britain’s leading sugar supplier to grow its medical cannabis.
